{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "10408913", "DateCompleted": {"Year": "1999", "Month": "07", "Day": "15"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "20"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0304-3835", "JournalIssue": {"Volume": "139", "Issue": "1", "PubDate": {"Year": "1999", "Month": "May", "Day": "03"}}, "Title": "Cancer letters", "ISOAbbreviation": "Cancer Lett"}, "ArticleTitle": "Induction of mitochondrial Apo2.7 molecules and generation of reactive oxygen-intermediates in cultured lymphocytes by the toxic proteins from Viscum album L.", "Pagination": {"StartPage": "79", "EndPage": "88", "MedlinePgn": "79-88"}, "Abstract": {"AbstractText": ["We analysed mitochondrial alterations in human lymphocytes incubated with toxins exerting RNA and/or protein synthesis/transport inhibitory activity. We found that all toxins known to affect macromolecule synthesis, such as ricin from Ricinus communis, mistletoe lectin I (ML I) from Viscum album, cycloheximide, actinomycin D, and brefeldin A but also the thionins from Viscum album (viscotoxins; VT) generated reactive oxygen intermediates (ROI) and induced expression of newly described mitochondrial membrane proteins Apo2.7, however, with different kinetics. Apart from a rapid permeabilisation of cell membranes by the VT with swelling of mitochondria, loss of their cristae and ROI generation within 2-4 h, the majority of the cells may have received a distinct 'death signal' resulting in an induction of Apo2.7 molecules within 24 h. In contrast, protein synthesis/transport inhibition may signal for apoptosis within 24 h by decreasing distinct 'survival promotors' which remain to be characterised."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Krebsforschung Herdecke, Department of Applied Immunology, University of Witten/Herdecke, Communal Hospital Herdecke, Germany. arbuess@t-online.de"}], "LastName": "B\u00fcssing", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Wagner", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Wagner", "ForeName": "B", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Stein", "ForeName": "G M", "Initials": "GM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Schietzel", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Schaller", "ForeName": "G", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Pf\u00fcller", "ForeName": "U", "Initials": "U"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "Cancer Lett", "NlmUniqueID": "7600053", "ISSNLinking": "0304-3835"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Annexin A5"}, {"RegistryNumber": "0", "NameOfSubstance": "Antibiotics, Antineoplastic"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphatidylserines"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Toxins, Biological"}, {"RegistryNumber": "1CC1JFE158", "NameOfSubstance": "Dactinomycin"}, {"RegistryNumber": "9M140C3R39", "NameOfSubstance": "viscotoxin"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Annexin A5"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antibiotics, Antineoplastic"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Dactinomycin"}, {"QualifierName": [], "DescriptorName": "Flow Cytometry"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "In Situ Nick-End Labeling"}, {"QualifierName": [], "DescriptorName": "Kinetics"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lymphocytes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Membrane Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Mistletoe"}, {"QualifierName": ["metabolism"], "DescriptorName": "Mitochondria"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylserines"}, {"QualifierName": [], "DescriptorName": "Plant Proteins"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Toxins, Biological"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "7", "Day": "17"}, {"Year": "1999", "Month": "7", "Day": "17", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "7", "Day": "17", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10408913", "10.1016/s0304-3835(99)00010-5", "S0304-3835(99)00010-5"]}}]}